Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy - Yusoh - 2020 - ChemMedChem - Wiley Online Library
Cancers | Free Full-Text | Platinum Complexes in Colorectal Cancer and Other Solid Tumors
The side effects of platinum-based chemotherapy drugs: a review for chemists - Dalton Transactions (RSC Publishing)
Cancers | Free Full-Text | Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer (Review)
Frontiers | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
The rediscovery of platinum-based cancer therapy | Nature Reviews Cancer
40 years of platinum drugs for cancer – in C&EN – Compound Interest
Understanding and Improving Platinum Anticancer Drugs – Phenanthriplatin | Anticancer Research
The platinum-based anticancer drugs which have gained marketing... | Download Scientific Diagram
Platinum-based anticancer drugs used in the clinic | Download Table
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer - ScienceDirect
The rediscovery of platinum-based cancer therapy | Nature Reviews Cancer
Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy - ScienceDirect
Platinum containing medications: Video & Anatomy | Osmosis
Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan | Published in Journal of Health Economics and Outcomes Research
Molecular Mechanisms of Platinum Resistance in Ovarian Cancer | IntechOpen
The rediscovery of platinum-based cancer therapy | Nature Reviews Cancer
Product Blog
The resurgence of platinum-based cancer chemotherapy | Nature Reviews Cancer
Platinum Complex - an overview | ScienceDirect Topics
A source of hope for platinum-resistant ovarian cancer? - The Lancet
Periodic graphics: Platinum drugs for cancer
